264 related articles for article (PubMed ID: 7692822)
1. [Anticancer and side effect of arterial subsegmental chemoembolization using cisplatinum/pirarubicin lipiodol suspension (CTLS) for hepatocellular carcinoma].
Inoue H; Miyazono N; Kanetsuki I; Hori A; Tanaka D; Fukukura Y; Matsumoto Y; Nishida H; Ueno K; Nakajo M
Gan To Kagaku Ryoho; 1993 Oct; 20(13):1973-6. PubMed ID: 7692822
[TBL] [Abstract][Full Text] [Related]
2. [Anticancer effect and side effect of arterial chemoembolization using cis-diamine-dichloroplatinum (II)/4-0-tetrahydropyranyl-adriamycin-lipiodol (CTL) suspension on hepatocellular carcinoma].
Takeshita T; Inoue H; Miyazono N; Hori A; Harada O; Satake M; Kanetsuki I; Nishida H; Sagara K; Shinmaki H
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1867-72. PubMed ID: 1381572
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
Ueno K; Miyazono N; Inoue H; Nishida H; Kanetsuki I; Nakajo M
Cancer; 2000 Apr; 88(7):1574-81. PubMed ID: 10738215
[TBL] [Abstract][Full Text] [Related]
5. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C; Sakata Y; Shimamura Y; Jinno K; Takahashi A; Takayasu K; Tamura K; Nagasue N; Nakanishi Y; Makino M; Masuzawa M; Yumoto Y; Mori T; Oda T
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
Mabed M; Esmaeel M; El-Khodary T; Awad M; Amer T
Eur J Cancer Care (Engl); 2009 Sep; 18(5):492-9. PubMed ID: 19453695
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
Raoul JL; Guyader D; Bretagne JF; Heautot JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356
[TBL] [Abstract][Full Text] [Related]
8. Intraarterial injection therapy of newly developed cisplatin-phosphatidyl choline-lipiodol suspension for hepatocellular carcinoma.
Isomoto I; Aikawa H; Mori H; Matsunaga N; Ajimu A; Fukuda T; Ogasawara M
Radiat Med; 1992; 10(1):19-25. PubMed ID: 1374923
[TBL] [Abstract][Full Text] [Related]
9. Suitable blending method of lipiodol-cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature.
Takaki Y; Kaminou T; Shabana M; Ihaya T; Otsubo K; Ogawa T
Hepatogastroenterology; 2008; 55(81):202-6. PubMed ID: 18507107
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy with Cisplatin-Phosphatidyl-choline-Lipiodol (CPL) suspension in unresectable hepatocellular carcinoma].
Aoki Y; Hirai K; Yamashita K; Noguchi H; Sakai T; Majima Y; Tanikawa K; Inoue H; Okano Y; Hitoshi T
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3066-9. PubMed ID: 2476969
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and toxicity of transcatheter arterial chemoembolization with Cisplatin suspended in lipiodol for unresectable hepatocellular carcinoma].
Uyama N; Hatano E; Maetani Y; Isoda H; Shibata T; Taura K; Oe S; Naito M; Yasuchika K; Fujii H; Ikai I; Uemoto S
Gan To Kagaku Ryoho; 2008 May; 35(5):775-80. PubMed ID: 18487912
[TBL] [Abstract][Full Text] [Related]
12. [Hepatocellular carcinoma treated by intraarterial injection of adriamycin/mitomycin C oil suspension alone or combined with cis-diaminodichloroplatinum].
Inoue H; Miyazono N; Hori A; Kanetsuki I; Tanaka D; Fukukura Y; Tsuchimochi S; Hokotate H; Ida K; Ikeda K
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1049-53. PubMed ID: 8390227
[TBL] [Abstract][Full Text] [Related]
13. Unresectable hepatocellular carcinoma: survival and prognostic factors after lipiodol chemoembolisation in 89 patients.
Dumortier J; Chapuis F; Borson O; Davril B; Scoazec JY; Poncet G; Henry L; Boillot O; Mion F; Berger F; Partensky C; Paliard P; Valette PJ
Dig Liver Dis; 2006 Feb; 38(2):125-33. PubMed ID: 16389002
[TBL] [Abstract][Full Text] [Related]
14. Hypersensitivity reactions to transcatheter chemoembolization with cisplatin and Lipiodol suspension for unresectable hepatocellular carcinoma.
Kawaoka T; Aikata H; Katamura Y; Takaki S; Waki K; Hiramatsu A; Takahashi S; Hieda M; Kakizawa H; Chayama K
J Vasc Interv Radiol; 2010 Aug; 21(8):1219-25. PubMed ID: 20619676
[TBL] [Abstract][Full Text] [Related]
15. [Transarterial chemoembolization with high dose iodized oil for the treatment of large hepatocellular carcinoma].
Chen M; Li J; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):165-7. PubMed ID: 11783027
[TBL] [Abstract][Full Text] [Related]
16. [Intra-arterial injection of cisplatin suspension in lipiodol (LPS) for the treatment of advanced hepatocellular carcinoma (stage IV)].
Shibata J; Kimura S; Nakashima M; Nakazono K; Miyase S; Sakai M; Fujiyama S; Sato T
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):357-64. PubMed ID: 2539053
[TBL] [Abstract][Full Text] [Related]
17. [The results of the chemoembolization of advanced hepatocellular carcinomas. The effect on the survival times, morphological findings and tumor markers].
Wickenhöfer R; Hasan I; Schüller H; Reiser M; Hartlapp JH
Rofo; 1992 Apr; 156(4):328-32. PubMed ID: 1373966
[TBL] [Abstract][Full Text] [Related]
18. [A clinical trial of transarterial chemoembolization for hepatocellular carcinoma using 4'-0-tetrahydropyranyladriamycin].
Izumi N; Goto Y
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1303-7. PubMed ID: 1695081
[TBL] [Abstract][Full Text] [Related]
19. [Transarterial "pile-up" infusion therapy of cisplatin and lipiodol emulsion in hepatic malignancies without TAE (transcatheter arterial embolization)].
Onohara S; Ogita M; Shimada J; Hiraki Y; Abeyama K; Nakajo M
Gan To Kagaku Ryoho; 1992 Mar; 19(3):315-21. PubMed ID: 1311912
[TBL] [Abstract][Full Text] [Related]
20. [Chemoembolization therapy of hepatocellular carcinoma-antitumor effect and side effect].
Saito Y; Sasaki T; Tarusawa K; Midorikawa H; Kanehira J; Ikami I; Yodono H; Takekawa SD
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3283-9. PubMed ID: 2848458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
